To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.
Trial details
- Registry ID
- NCT06429722
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as BTRX-335140; CYM-53093; Navacaprant
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.NCT06429722 | NMRA | Phase 2 | Completed | 2025-04-09Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |